Status:
RECRUITING
Upper Limb Somatosensory Discrimination Therapy and Dose-matched Motor Therapy in Children and Adolescents With Unilateral Cerebral Palsy
Lead Sponsor:
Hilde Feys
Collaborating Sponsors:
Hasselt University
ETH Zurich
Conditions:
Cerebral Palsy, Spastic
Hemiplegic Cerebral Palsy
Eligibility:
All Genders
7-15 years
Phase:
PHASE2
Brief Summary
A randomized, controlled, and evaluator-blinded trial will be carried out to investigate the effects of 8 weeks of upper limb somatosensory discrimination therapy compared to an equal dose of motor th...
Detailed Description
BACKGROUND: Although cerebral palsy has primarily been defined as a motor disorder, research has shown that up to 90% of children and adolescents with unilateral cerebral palsy also present with somat...
Eligibility Criteria
Inclusion
- Congenital or acquired, predominantly spastic unilateral cerebral palsy;
- Aged 7 to 15 years;
- Minimal ability to actively grasp and hold an object (modified House Functional Classification System ≥4);
- Having a confirmed impairment in tactile function as objectified using a clinical assessment battery containing assessments of tactile registration and tactile perception; and
- Sufficient cooperation to comprehend and complete the test and therapy procedures;
Exclusion
- Botulinum toxin-A injections six months prior to testing;
- A history of upper limb surgery one year prior to testing;
- Severe comorbidities hindering test assessments (e.g., severe cognitive problems); and
- Inability to communicate in Dutch.
Key Trial Info
Start Date :
December 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06006065
Start Date
December 9 2023
End Date
December 1 2024
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KU Leuven
Leuven, Vlaams-Brabant, Belgium, 3000